A retrospective study of first line bevacizumab or cetuximab containing regimens assessing treatment patterns and outcomes in patients with KRAS wild type (WT) metastatic colorectal cancer (mCRC)
Latest Information Update: 06 Apr 2016
At a glance
- Drugs Bevacizumab (Primary) ; Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 06 Apr 2016 New trial record